Glucose Sensing by MondoA:Mlx Complexes: a Role for Hexokinases and Direct Regulation of Thioredoxin-interacting Protein Expression
Overview
Authors
Affiliations
Glucose is a fundamental metabolite, yet how cells sense and respond to changes in extracellular glucose concentration is not completely understood. We recently reported that the MondoA:Mlx dimeric transcription factor directly regulates glycolysis. In this article, we consider whether MondoA:Mlx complexes have a broader role in sensing and responding to glucose status. In their latent state, MondoA:Mlx complexes localize to the outer mitochondrial membrane, yet shuttle between the mitochondria and the nucleus. We show that MondoA:Mlx complexes accumulate in the nucleus in response to glucose and 2-deoxyglucose (2-DG). Furthermore, nuclear localization of MondoA:Mlx depends on the enzymatic activity of hexokinases. These enzymes catalyze conversion of glucose to glucose-6-phosphate (G6P), which is the first step in the glycolytic pathway. Together, these findings suggest that MondoA:Mlx monitors intracellular G6P concentration and translocates to the nucleus when levels of this key metabolite increase. Transcriptional profiling experiments demonstrate that MondoA is required for >75% of the 2-DG-induced transcription signature. We identify thioredoxin-interacting protein (TXNIP) as a direct and glucose-regulated MondoA:Mlx transcriptional target. Furthermore, MondoA:Mlx complexes, via their regulation of TXNIP, are potent negative regulators of glucose uptake. These studies suggest a key role for MondoA:Mlx complexes in the adaptive transcriptional response to changes in extracellular glucose concentration and peripheral glucose uptake.
Sulforaphane acutely activates multiple starvation response pathways.
Plafker K, Georgescu C, Pezant N, Pranay A, Plafker S Front Nutr. 2025; 11:1485466.
PMID: 39867556 PMC: 11758633. DOI: 10.3389/fnut.2024.1485466.
Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in Citrin Deficiency.
Tiwari V, Jin B, Sun O, Lopez Gonzalez E, Chen M, Wu X bioRxiv. 2025; .
PMID: 39763913 PMC: 11703153. DOI: 10.1101/2024.12.27.630525.
Freie B, Ibrahim A, Carroll P, Bronson R, Augert A, MacPherson D bioRxiv. 2024; .
PMID: 39386474 PMC: 11463667. DOI: 10.1101/2024.09.21.614255.
The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas.
Deng J, Pan T, Wang D, Hong Y, Liu Z, Zhou X EMBO Mol Med. 2024; 16(9):2080-2108.
PMID: 39103698 PMC: 11393413. DOI: 10.1038/s44321-024-00105-2.
Systemic Deletion of ARRDC4 Improves Cardiac Reserve and Exercise Capacity in Diabetes.
Nakayama Y, Kobayashi S, Masihuddin A, Abdali S, Seneviratne A, Ishii S Circ Res. 2024; 135(3):416-433.
PMID: 38946541 PMC: 11257811. DOI: 10.1161/CIRCRESAHA.123.323158.